期刊文献+

VEGF CD44v6 MMP-9在子宫内膜异位症组织中的表达及临床意义 被引量:8

下载PDF
导出
摘要 目的探讨血管内皮生长因子(vascular endothelial growth factor,VEGF)、黏附分子CD44v6、基质金属蛋白酶-9(matrix metalloproteinases-9,MMP-9)在子宫内膜异位症发病机制中的作用及临床意义。方法通过免疫组化S-P法分别对60例卵巢异位内膜、52例子宫内膜异位症在位子宫内膜和44例正常子宫内膜组织分别行VEGF、CD44v6和MMP-9的检测,并进行观察和对比。结果 VEGF、CD44v6、MMP-9在卵巢异位内膜中的表达与在位内膜组和正常内膜组比较,有明显增强(P<0.01);在位内膜与正常子宫内膜相比,VEGF在位内膜中的表达高于正常内膜中的表达,有统计学意义(P<0.01),CD44v6及MMP-9在在位内膜中的表达略高于正常内膜中的表达,但无统计学意义(P>0.05)。结论 VEGF、CD44v6、MMP-9在卵巢异位内膜中呈高表达状态,异位内膜组VEGF和CD44v6之间呈正相关(r1=0.462,χ2=42.038,P=0.000);MMP-9与CD44v6之间呈正相关(r2=0.558,χ2=70.534,P=0.000);MMP-9与VEGF呈正相关(r3=0.397,χ2=29.187,P=0.000),表明与异位内膜的高侵袭性和高血管新生能力有关,可能在EMS的发生发展中起重要作用。
出处 《济宁医学院学报》 2013年第2期124-126,132,共4页 Journal of Jining Medical University
  • 相关文献

参考文献13

  • 1O Down MJ, Philipp EE. The history of obstetrics and gyne-cology[M]. New York: The Part henon Publishing Group,2000:523-525.
  • 2Takehara M, Veda M, Yamashita Y,et al. Vascular endothe-lial growth factor A and C gene expression in endometriosis[J]. HumpathoK2004,35(11) :1369-1375.
  • 3Kim SH, Choi YM,Choung SH, et al. Vascular endothelialgrowth factor gene +405C/G polymorphism advanced stageendometriosis[J], Hum Reprod,2005 ,20(10) ; 2904-2908.
  • 4Pepper MS, Ferrara N, Orci L, et al. Potent synergism be-tween vascular endothelial grower factor and basic fibroblastgrowth factor in the induction of angiogenesis in vitro[J].Biochen Biophys Res Commun, 1992·189(2) : 824-831.
  • 5Fujii EY, Nakayama M, Nakagawa A. Concentrations of re-ceptor for advanced glycation end products, VEGF and CMLin plasma, follicular fluid,and peritoneal fluid in women withand without endometriosis[J]. Reprod Sci, 2008, 15 ( 10):1066-1074.
  • 6辛晓燕,李洁,严瑞兰,王德堂.血管生成因子在子宫内膜异位症中的作用[J].现代妇产科进展,2001,10(3):187-189. 被引量:20
  • 7Szamatowicz J,Laudanskip, Tomaszewska I,et al. Matrix-metalloproteinase-9 and tissue inhibitor of matrix metallo-proteinase-1 :a possible role in the pathogenesis of endome-triosis[J]. Hum Reprod,2002,17(2) . 284-288.
  • 8沈蓉,田永杰.MMP-9、TIMP-1在子宫内膜异位症患者子宫内膜中的表达及意义[J].山东医药,2006,46(17):20-22. 被引量:6
  • 9Nap AW,Griffion AW,Dunselmang A,et al. Anti-angiogene-sistherapy for endometriosis [ J]. J Clim Endocdol Metal,2004,89(3):1089-1095.
  • 10Evers JL, Willebrand D. The basement membrance in endo-metriosis[J]. Fertil Steril, 1987,47(3) :505-507.

二级参考文献20

  • 1周小会,李兆艾.基质金属蛋白酶及其抑制物与子宫内膜异位症[J].中国药物与临床,2004,4(4):291-293. 被引量:2
  • 2[1]Giudice,Tazuke S, Swiersz L .Status of current research on endometriosis[J] .J Reprod, 1998,43(3 Suppl):252-262
  • 3[2]Sampson J. Peritoneal endometriosis due to mentral dissemination of endometrial tissue into the peritoneal cavity[J].Am J Obstet Gynecol, 1927,14:422-469
  • 4[3]Venrini PL,Semino A,Dec Cecco L.The biological basis of medical treatment of endometriosis[J]. Gynecol Endocrinol,1995,9:259-266
  • 5[4]Heldin CH, Westemark B. Platelet-derived growth factor:Mechainsm of action and possible in vivo function[J]. Cell Regul, 1990,1:555-566
  • 6[5]Mclaren J,Prentice A,Chamock-Jones DS, et al. Vescular endothelial growth factor(VEGF)concentrations are elevated in peritoneal fluid from women with endometriosis[J]. Hum Reprod, 1996,11:220-223
  • 7[6]Osteen KG, Hill GA, Hargrove JT, et al. Development of a method to isolate and culture highly purified populations of stromal and epithelial cells from human endometrial biopsy specimens[J]. Fertil Steril, 1989,52:965-972
  • 8[7]Gasparini G, Harris A. Clinical importance of the determination of tumor angiogenesis in breast carcinoma:Much more than a new prognostic tool[J].J Clin Oncol,1995,13:765-782
  • 9[8]Folkman J.Seminars in medicine of the Beth Israel. Hospital,Boston. Clinical applications of research on angiogenesis[seecomments][J].N Engl J Med,1995,233:1757-1763
  • 10[9]Munson L,Upadhyaya NB,Van S.Platelet-derived growth factor promotes endometriosis and epithelial cell proliferation[J].Am J Obstet Gynecol,1995,173:1820-1825

共引文献39

同被引文献84

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部